The Potential of Procalcitonin as a Biomarker in Exacerbations of COPD

被引:0
作者
Rodriguez, Moises [1 ]
Varon, Joseph [2 ]
机构
[1] Dorrington Med Associates, Houston, TX USA
[2] Univ Houston, Coll Med, Houston, TX 77204 USA
关键词
C-REACTIVE PROTEIN; SEPSIS;
D O I
10.2174/1573398X1902230606164833
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:83 / 84
页数:2
相关论文
共 50 条
  • [21] Systemic Biomarkers in Exacerbations of COPD
    Koutsokera, Angela
    Stolz, Daiana
    Loukides, Stelios
    Kostikas, Konstantinos
    CHEST, 2012, 141 (02) : 396 - 405
  • [22] Effect of procalcitonin on the prognosis of patients with COPD
    Gong Chen
    Yang Ying
    Chen Minli
    Xie Zhengfu
    BIOMEDICAL REPORTS, 2020, 12 (06) : 313 - 318
  • [23] Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injury
    Nakamura, Yoshihiko
    Murai, Akira
    Mizunuma, Mariko
    Ohta, Daiki
    Kawano, Yasumasa
    Matsumoto, Norihiko
    Nishida, Takeshi
    Ishikura, Hiroyasu
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (3-4) : 257 - 263
  • [24] Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target
    Becker, Kenneth L.
    Snider, Richard
    Nylen, Eric S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (02) : 253 - 264
  • [25] Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases
    Koho, N.
    Rajamaki, M. M.
    Viitanen, S. J.
    VETERINARY CLINICAL PATHOLOGY, 2024, 53 (02) : 273 - 279
  • [26] Procalcitonin and acute coronary syndromes: a new biomarker for an old disease
    Biasucci, Luigi M.
    Biasillo, Gina
    Stefanelli, Antonella
    INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (05) : 363 - 365
  • [27] Use of procalcitonin as a biomarker for sepsis in moderate to major paediatric burns
    Hollen, Linda
    Hughes, Ryan
    Dodds, Nick
    Coy, Karen
    Marlow, Karen
    Pullan, Nicola
    Davies, Julie
    Dailami, Narges
    Keating, Katrina
    Falder, Sian
    Shah, Mamta
    Young, Amber
    TRAUMA-ENGLAND, 2019, 21 (03): : 192 - 200
  • [28] Procalcitonin as a biomarker for infection-related mortality in cancer patients
    Sedef, Ali M.
    Kose, Fatih
    Mertsoylu, Huseyin
    Ozyilkan, Ozgur
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2015, 9 (02) : 168 - 173
  • [29] Procalcitonin as a Biomarker for Toxic Shock Syndrome
    Kato, Madoka
    Kaneko, Sakae
    Takagaki, Kenji
    Kohayagawa, Yoshitaka
    Watanabe, Tessin
    Yoshida, Yuichi
    Yamamoto, Osamu
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (04) : 441 - 443
  • [30] Procalcitonin (PCT)- a biomarker in the diagnostics of sepsis
    Zulauf, N.
    Passek, K.
    Wanke, E.
    Oremek, G. M.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2021, 71 (01): : 29 - 31